AIM ▼ -5.6% - AIM ImmunoTech Inc. $AIM - AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data 01-OCT-2026 09:02 AM ET